login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Vascular Solutions launches SuperCross FT Microcatheter


Tuesday, 07 Aug 2012 16:10
SuperCross
SuperCross

Vascular Solutions has launched the SuperCross FT, a new flexible-tip version of its line of SuperCross microcatheters. SuperCross FT has been designed to address the majority of complex interventional procedures in which a flexible tipped microcatheter is needed.


Vascular Solutions’ family of SuperCross microcatheters consists of single lumen, over-the-wire microcatheters designed for guidewire support and exchange, as well as the infusion of contrast media or therapeutic agents in the coronary and peripheral vasculature. The full-length braided stainless steel construction and low profile of the SuperCross microcatheters allow access to small and tortuous vessels and enhance the ability to cross plaque lesions.

“SuperCross FT is the latest offering in our popular line of microcatheters, and was engineered specifically in response to physician requests for a more flexible tip that provides superior deliverability over a guidewire in tortuous anatomy,” said Howard Root, CEO of Vascular Solutions.

Vascular Solutions’ original SuperCross microcatheter was launched in January 2011 with a straight tip that was designed for cases in which physicians needed extra support for the wire to advance past a challenging lesion. The next version introduced, SuperCross AT, features angled tip designs for directing guidewire placement in bifurcated lesions, and is offered in three pre-set tip configurations: 45, 90 and 120 degree angles.

The new SuperCross FT is compatible with 0.014-inch guidewires. Also like the original straight-tip model, SuperCross FT is available in 130cm and 150cm working lengths, has a fully embedded gold distal marker band, a clear proximal catheter hub, two depth mark indicators to aid in determining position within the guide catheter, and a hydrophilic coating on the distal 40cm to enhance deliverability to the target vasculature.

All versions of the SuperCross microcatheters are intended to be used in conjunction with steerable guidewires to access discrete regions of the coronary and/or peripheral vasculature. They may be used to facilitate placement and exchange of guidewires and other interventional devices and to subselectively infuse/deliver diagnostic and therapeutic agents.




Add New Comment

Most popular


Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years
Wednesday, 19 Nov 2014
Three-year follow-up results of patients treated with the Supera stent show that nominal deployment or slight compression of the device delivers the best outcomes in terms of durability, and that ... Live from VEITH 2014: SUPERB results show 94% freedom from reintervention with nominal deployment of Supera at three years

New deep vein thrombosis guidelines: What you need to know
Thursday, 23 Oct 2014
Suresh Vedantham spoke to Interventional News on the latest from the paper “Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus ... New deep vein thrombosis guidelines: What you need to know

Bioresorbable scaffolds can produce comparable acute results to metal stents
Tuesday, 04 Nov 2014
Speaking at the Asian Society for Vascular Surgery meeting (5–7 September, Hong Kong, China), Andrew Holden commented that studies indicate that bioresorbable scaffolds can produce comparable acute ... Bioresorbable scaffolds can produce comparable acute results to metal stents

Features


Stentoplasty: An “exciting frontier” in spinal augmentation
Thursday, 27 Nov 2014
Stentoplasty, or vertebral body stenting, represents the next step in the evolution of cement spinal augmentation where a stent is placed within the vertebral body followed by infusion of cement. Stentoplasty: An “exciting frontier” in spinal augmentation

CO2 angiography should be more widely used
Thursday, 27 Nov 2014
CO2 angiography can decrease both morbidity and mortality for patients, in certain clinical scenarios. For those driven by economics, the cost of 100cc of CO2 is approximately three cents. Its use is ... CO2 angiography should be more widely used

Profiles


Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions